Literature DB >> 15184926

The use of autologous serum tears in persistent corneal epithelial defects.

A L Young1, A C O Cheng, H K Ng, L L Cheng, G Y S Leung, D S C Lam.   

Abstract

PURPOSE: Persistent corneal epithelial defects (PED) present a very challenging problem to anterior segment surgeons. Autologous serum tears had been demonstrated to be beneficial in the treatment of PED. The current study was conducted to review the local spectrum of indications and to examine the outcome of autologous serum tear usage.
METHODS: All cases of PED treated with autologous serum tears at a tertiary referral centre for the period August 1999 - July 2001 were identified and reviewed.
RESULTS: A total of 10 eyes from 10 patients were identified (5OD : 5OS). The gender ratio was 7M : 3F and the mean age was 36.8 (range 17-73) years old. The mean duration of PED before the usage of autologous serum tears was 22.4+/-69.6 days. Six eyes healed within 2 weeks, but two eyes failed to heal after 1 month of treatment and two patients defaulted follow-up. No adverse effects were observed with the addition of autoserum tears.
CONCLUSIONS: The results of the current study correlated well with previous reported studies. Autologous serum tears may be considered as a valuable adjunct in the management of recalcitrant cases of PED.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184926     DOI: 10.1038/sj.eye.6700721

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  19 in total

1.  Differential contributions of impaired corneal sensitivity and reduced tear secretion to corneal epithelial disorders.

Authors:  Teruo Nishida; Tai-Ichiro Chikama; Mitsuru Sawa; Kazunori Miyata; Takaaki Matsui; Kyoko Shigeta
Journal:  Jpn J Ophthalmol       Date:  2011-11-11       Impact factor: 2.447

Review 2.  Novel Therapy to Treat Corneal Epithelial Defects: A Hypothesis with Growth Hormone.

Authors:  Barbara Wirostko; MaryJane Rafii; David A Sullivan; Julia Morelli; Juan Ding
Journal:  Ocul Surf       Date:  2015-03-28       Impact factor: 5.033

3.  Management strategies for persistent epithelial defects of the cornea.

Authors:  Lee R Katzman; Bennie H Jeng
Journal:  Saudi J Ophthalmol       Date:  2014-07-02

4.  Fingerprick autologous blood: a novel treatment for dry eye syndrome.

Authors:  J Than; S Balal; J Wawrzynski; N Nesaratnam; G M Saleh; J Moore; A Patel; S Shah; B Sharma; B Kumar; J Smith; A Sharma
Journal:  Eye (Lond)       Date:  2017-06-16       Impact factor: 3.775

5.  Effect of autologous platelet-rich plasma on persistent corneal epithelial defect after infectious keratitis.

Authors:  Kyoung Min Kim; Yong-Tae Shin; Hong Kyun Kim
Journal:  Jpn J Ophthalmol       Date:  2012-09-13       Impact factor: 2.447

Review 6.  Current and Upcoming Therapies for Ocular Surface Chemical Injuries.

Authors:  Alireza Baradaran-Rafii; Medi Eslani; Zeeshan Haq; Ebrahim Shirzadeh; Michael J Huvard; Ali R Djalilian
Journal:  Ocul Surf       Date:  2016-09-17       Impact factor: 5.033

7.  Evaluation of the efficacy of 50% autologous serum eye drops in different ocular surface pathologies.

Authors:  Francesco Semeraro; Eliana Forbice; Osvaldo Braga; Alessandro Bova; Attilio Di Salvatore; Claudio Azzolini
Journal:  Biomed Res Int       Date:  2014-07-22       Impact factor: 3.411

Review 8.  Use of umbilical cord serum in ophthalmology.

Authors:  Kyung Chul Yoon
Journal:  Chonnam Med J       Date:  2014-12-17

9.  The use of autologous serum eye drops for the treatment of ocular surface disorders.

Authors:  Estela García-Martín; Sagrario Pernía-López; R M Romero Jiménez; Blanca García-Valcárcel; Pilar A Martínez-Ortega; María Sanjurjo-Saez
Journal:  Eur J Hosp Pharm       Date:  2018-05-04

10.  Topical 100% serum eye drops for treating corneal epithelial defect after ocular surgery.

Authors:  Kaevalin Lekhanont; Passara Jongkhajornpong; Lulin Choubtum; Varintorn Chuckpaiwong
Journal:  Biomed Res Int       Date:  2013-07-30       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.